Sildenafil Tablet, Film Coated
Product Images NDC 68071-3908

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 68071-3908). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3908 1)

This is a medication label for Sildenafil 100mg produced by NuCare Pharmaceuticals, Inc. It includes important information such as lot numbers, NDC codes, expiration dates, and storage instructions. The label warns to keep the medication out of reach of children and provides contact information for reporting side effects.*

FDA Label Image

Figure 1 (Sildenafil Fig1)

This is a study evaluating the change in sitting systolic blood pressure of healthy volunteers after administration of 100mg of Sildenafil. The readings were taken before and after the dose at specified time intervals. The data is presented in a table format.*

FDA Label Image

Figure 2 (Sildenafil Fig2)

This text shows a comparison of the change in systolic blood pressure (SBP) over time for two conditions: Doxazosin + Placebo and Doxazosin + Sildenafil 25 mg. The data indicates the SBP values at different time points post-dose.*

FDA Label Image

Figure 3 (Sildenafil Fig3)

FDA Label Image

Figure 4 (Sildenafil Fig4)

This text provides a comparison between the impact of Doxazosin + Sildenafil 100 mg versus Doxazosin + Placebo on mean standing systolic blood pressure changes from baseline over time after dosing. The chart (Figure 4) likely shows how the two combinations affect blood pressure at different time points post-dosing.*

FDA Label Image

Figure 5 (Sildenafil Fig5)

This text provides information on the mean sildenafil plasma concentrations in healthy male volunteers over a period of time post-dose in hours. The data represents the effects of a commercial tablet and shows concentrations at different time points. This information can be useful for understanding the pharmacokinetics of sildenafil in the body.*

FDA Label Image

Figure 6. Effect Of Sildenafil And Placebo On Maintenance Of Erection By Baseline Score (Sildenafil Fig6)

FDA Label Image

Sildenafile Fig 7 (Sildenafil Fig7)

FDA Label Image

Structure (Sildenafil Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.